{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T02:19:57Z","timestamp":1788747597496,"version":"build-2803163510"},"reference-count":55,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2020,12,1]]},"DOI":"10.1001\/jamasurg.2020.3280","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T15:29:48Z","timestamp":1602689388000},"page":"1152","source":"Crossref","is-referenced-by-count":32,"title":["Evaluation and Treatment of Patients With Hypercortisolism"],"prefix":"10.1001","volume":"155","author":[{"given":"Barbra S.","family":"Miller","sequence":"first","affiliation":[{"name":"Division of Endocrine Surgery, University of Michigan, Ann Arbor"},{"name":"Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor"},{"name":"now with Division of Surgical Oncology, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Auchus","sequence":"additional","affiliation":[{"name":"Division of Endocrine Surgery, University of Michigan, Ann Arbor"},{"name":"Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"srv200007r1","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/cen.2011.75.issue-4","article-title":"Mortality and morbidity in Cushing\u2019s syndrome in New Zealand.","volume":"75","author":"Bolland","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"srv200007r2","first-page":"117","article-title":"Incidence and late prognosis of Cushing\u2019s syndrome: a population-based study.","volume":"86","author":"Lindholm","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"srv200007r3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000314297","article-title":"Epidemiology of Cushing\u2019s syndrome.","volume":"92","author":"Steffensen","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"3","key":"srv200007r4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1530\/EJE-11-0272","article-title":"The European Registry on Cushing\u2019s syndrome: 2-year experience: baseline demographic and clinical characteristics.","volume":"165","author":"Valassi","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"srv200007r5","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"srv200007r6","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1530\/EJE-10-1147","article-title":"AME position statement on adrenal incidentaloma.","volume":"164","author":"Terzolo","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"srv200007r7","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3390\/ijerph15030431","article-title":"An empirical study of chronic diseases in the United States: a visual analytics approach.","volume":"15","author":"Raghupathi","year":"2018","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"srv200007r8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21037\/gs","article-title":"Cardiovascular risk and mortality in patients with active and treated hypercortisolism.","volume":"9","author":"Li","year":"2020","journal-title":"Gland Surg"},{"issue":"6","key":"srv200007r9","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1210\/jc.2003-030138","article-title":"Hypertension and the cortisol-cortisone shuttle.","volume":"88","author":"Quinkler","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"srv200007r10","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1093\/ajh\/hpz125","article-title":"New-onset resistant hypertension in a newly diagnosed prostate cancer patient.","volume":"32","author":"Klomjit","year":"2019","journal-title":"Am J Hypertens"},{"issue":"12","key":"srv200007r11","first-page":"3617","article-title":"11 beta-Hydroxysteroid dehydrogenase activity in Cushing\u2019s syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome.","volume":"80","author":"Stewart","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"srv200007r12","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1161\/HYPERTENSIONAHA.109.134973","article-title":"Mineralocorticoid and glucocorticoid receptors stimulate epithelial sodium channel activity in a mouse model of Cushing syndrome.","volume":"54","author":"Bailey","year":"2009","journal-title":"Hypertension"},{"issue":"3","key":"srv200007r13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.bbadis.2013.05.029","article-title":"Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity.","volume":"1842","author":"Lee","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"srv200007r14","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1177\/0300060517725660","article-title":"Effect of hypercortisolism on bone mineral density and bone metabolism: a potential protective effect of adrenocorticotropic hormone in patients with Cushing\u2019s disease.","volume":"46","author":"Guo","year":"2018","journal-title":"J Int Med Res"},{"issue":"5","key":"srv200007r15","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline.","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"srv200007r16","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing\u2019s syndrome: an Endocrine Society clinical practice guideline.","volume":"100","author":"Nieman","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"srv200007r17","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1177\/0004563217704738","article-title":"Low dehydroepiandrosterone sulphate: a sensitive and specific test for the detection of subclinical hypercortisolism in adrenal incidentalomas.","volume":"54","author":"Stoddart","year":"2017","journal-title":"Ann Clin Biochem"},{"issue":"2","key":"srv200007r18","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s12020-014-0387-7","article-title":"DHEAS for the prediction of subclinical Cushing\u2019s syndrome: perplexing or advantageous?","volume":"48","author":"Yener","year":"2015","journal-title":"Endocrine"},{"issue":"2","key":"srv200007r19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1210\/jc.2014-3766","article-title":"Urine free cortisol in the diagnosis of Cushing\u2019s syndrome: is it worth doing and, if so, how?","volume":"100","author":"Raff","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"srv200007r20","first-page":"1440","article-title":"Subclinical Cushing\u2019s syndrome in patients with adrenal incidentaloma: clinical and biochemical features.","volume":"85","author":"Rossi","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"srv200007r21","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1210\/js.2019-00027","article-title":"Assay-specific spurious ACTH results lead to misdiagnosis, unnecessary testing, and surgical misadventure: a case series.","volume":"3","author":"Greene","year":"2019","journal-title":"J Endocr Soc"},{"issue":"2","key":"srv200007r22","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s12020-017-1268-7","article-title":"Interference in ACTH immunoassay negatively impacts the management of subclinical hypercortisolism.","volume":"56","author":"Yener","year":"2017","journal-title":"Endocrine"},{"issue":"22","key":"srv200007r23","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1056\/NEJMc1913160","article-title":"Adrenal crisis.","volume":"381","author":"Miller","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"srv200007r24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/cen.2017.86.issue-1","article-title":"Towards a universally accepted definition of subclinical Cushing\u2019s syndrome: subclinical autonomous hypercortisolism.","volume":"86","author":"Inder","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"srv200007r25","doi-asserted-by":"publisher","first-page":"M61","DOI":"10.1530\/EJE-15-0272","article-title":"Subclinical hypercortisolism: a state, a syndrome, or a disease?","volume":"173","author":"Di Dalmazi","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"srv200007r26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/MED.0000000000000159","article-title":"Update on subclinical Cushing\u2019s syndrome.","volume":"22","author":"Nieman","year":"2015","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"4","key":"srv200007r27","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1530\/EJE-14-0345","article-title":"Nonconformity in the clinical practice guidelines for subclinical Cushing\u2019s syndrome: which guidelines are trustworthy?","volume":"171","author":"Shen","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"srv200007r28","doi-asserted-by":"publisher","first-page":"R283","DOI":"10.1530\/EJE-16-0465","article-title":"Therapy of endocrine disease: improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing\u2019s syndrome: a systematic review and meta-analysis.","volume":"175","author":"Bancos","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"srv200007r29","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing\u2019s syndrome: a 15-year retrospective study.","volume":"2","author":"Di Dalmazi","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"srv200007r30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s40292-017-0182-7","article-title":"Clinical benefits of unilateral adrenalectomy in patients with subclinical hypercortisolism due to adrenal incidentaloma: results from a single center.","volume":"24","author":"Petramala","year":"2017","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"1","key":"srv200007r31","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.surg.2016.07.042","article-title":"Outcome of adrenalectomy for subclinical hypercortisolism and Cushing syndrome.","volume":"161","author":"Raffaelli","year":"2017","journal-title":"Surgery"},{"issue":"3","key":"srv200007r32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1530\/EJE-15-0977","article-title":"Adrenalectomy reduces the risk of vertebral fractures in patients with monolateral adrenal incidentalomas and subclinical hypercortisolism.","volume":"174","author":"Salcuni","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"srv200007r33","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1530\/EJE-15-0566","article-title":"Biochemical and clinical benefits of unilateral adrenalectomy in patients with subclinical hypercortisolism and bilateral adrenal incidentalomas.","volume":"173","author":"Perogamvros","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"srv200007r34","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/bjs.2015.102.issue-4","article-title":"Systematic review of surgical treatment of subclinical Cushing\u2019s syndrome.","volume":"102","author":"Iacobone","year":"2015","journal-title":"Br J Surg"},{"issue":"6","key":"srv200007r35","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.surg.2012.08.054","article-title":"Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing\u2019s syndrome.","volume":"152","author":"Iacobone","year":"2012","journal-title":"Surgery"},{"issue":"6","key":"srv200007r36","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/cen.2015.82.issue-6","article-title":"An analysis of different therapeutic options in patients with Cushing\u2019s syndrome due to bilateral macronodular adrenal hyperplasia: a single-centre experience.","volume":"82","author":"Albiger","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"srv200007r37","doi-asserted-by":"publisher","first-page":"M45","DOI":"10.1530\/EJE-15-0200","article-title":"Multiple aberrant hormone receptors in Cushing\u2019s syndrome.","volume":"173","author":"El Ghorayeb","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"srv200007r38","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00423-017-1569-6","article-title":"Posterior retroperitoneoscopic adrenal surgery for clinical and subclinical Cushing\u2019s syndrome in patients with bilateral adrenal disease.","volume":"402","author":"Lowery","year":"2017","journal-title":"Langenbecks Arch Surg"},{"issue":"1","key":"srv200007r39","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.surg.2015.05.034","article-title":"Cosyntropin stimulation testing on postoperative day 1 allows for selective glucocorticoid replacement therapy after adrenalectomy for hypercortisolism: results of a novel, multidisciplinary institutional protocol.","volume":"159","author":"Ortiz","year":"2016","journal-title":"Surgery"},{"issue":"8","key":"srv200007r40","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1210\/jc.2014-1401","article-title":"Adrenal function after adrenalectomy for subclinical hypercortisolism and Cushing\u2019s syndrome: a systematic review of the literature.","volume":"99","author":"Di Dalmazi","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"srv200007r41","first-page":"1085","article-title":"Time to recovery of the hypothalamic-pituitary-adrenal axis after curative resection of adrenal tumors in patients with Cushing\u2019s syndrome.","volume":"108","author":"Doherty","year":"1990","journal-title":"Surgery"},{"issue":"6","key":"srv200007r42","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.surg.2008.08.024","article-title":"Waiting for change: symptom resolution after adrenalectomy for Cushing\u2019s syndrome.","volume":"144","author":"Sippel","year":"2008","journal-title":"Surgery"},{"issue":"3","key":"srv200007r43","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s12020-016-1007-5","article-title":"Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome.","volume":"55","author":"Prete","year":"2017","journal-title":"Endocrine"},{"issue":"4","key":"srv200007r44","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1210\/jc.2014-3632","article-title":"Time to recovery of adrenal function after curative surgery for Cushing\u2019s syndrome depends on etiology.","volume":"100","author":"Berr","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"srv200007r45","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1530\/EJE-14-0556","article-title":"Management of endocrine disease: mortality remains increased in Cushing\u2019s disease despite biochemical remission: a systematic review and meta-analysis.","volume":"172","author":"van Haalen","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"srv200007r46","doi-asserted-by":"publisher","first-page":"821","DOI":"10.7326\/0003-4819-130-10-199905180-00015","article-title":"Long-term mortality after transsphenoidal surgery for Cushing disease.","volume":"130","author":"Swearingen","year":"1999","journal-title":"Ann Intern Med"},{"issue":"1","key":"srv200007r47","first-page":"117","article-title":"Incidence and late prognosis of cushing\u2019s syndrome: a population-based study.","volume":"86","author":"Lindholm","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"srv200007r48","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1210\/jc.2012-3582","article-title":"Multisystem morbidity and mortality in Cushing\u2019s syndrome: a cohort study.","volume":"98","author":"Dekkers","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"srv200007r49","doi-asserted-by":"publisher","first-page":"6348","DOI":"10.1210\/jc.2003-032180","article-title":"Transsphenoidal microsurgery for Cushing\u2019s disease: initial outcome and long-term results.","volume":"89","author":"Hammer","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"srv200007r50","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ando.2018.03.005","article-title":"Cardiovascular mortality in patients with subclinical Cushing.","volume":"79","author":"Morelli","year":"2018","journal-title":"Ann Endocrinol (Paris)"},{"issue":"12","key":"srv200007r51","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.1210\/jc.2014-3007","article-title":"Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas.","volume":"99","author":"Debono","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"srv200007r52","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1016\/j.jacc.2018.07.096","article-title":"Cushing syndrome is associated with subclinical LV dysfunction and increased epicardial adipose tissue.","volume":"72","author":"Maurice","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"srv200007r53","first-page":"117","article-title":"Incidence and late prognosis of Cushing\u2019s syndrome: a population-based study.","volume":"86","author":"Lindholm","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"srv200007r54","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1210\/jc.2018-02524","article-title":"Overall and disease-specific mortality in patients with Cushing disease: a Swedish nationwide study.","volume":"104","author":"Ragnarsson","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"srv200007r55","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S2213-8587(16)30005-5","article-title":"Mortality in patients with Cushing\u2019s disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study.","volume":"4","author":"Clayton","year":"2016","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2771374\/jamasurgery_miller_2020_rv_200007_1608067512.31897.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T03:08:21Z","timestamp":1608260901000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2771374"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2020.3280","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,1]]}}}